ArticleJournal of experimental & clinical cancer research : CR2025
Targeting ATR offers multifaceted treatment strategies involving RAD51-mediated compensatory DNA repair in bladder cancer.
Julia Pannhausen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.